{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:47:02Z","timestamp":1773283622041,"version":"3.50.1"},"reference-count":60,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The antimicrobial resistance of\n            <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n            , or pneumococcus, is a growing global problem. In our study, 3,571 invasive pneumococcal isolates, recovered from blood and cerebrospinal fluid samples from patients in Finland between the years 2002 and 2006, showed an increase in erythromycin nonsusceptibility from 16% to 28% (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.0001) over the 5-year study period, as well as a doubling of penicillin nonsusceptibility from 8% to 16% (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.0001). Erythromycin nonsusceptibility increased especially in isolates derived from 0- to 2-year-old children and was 46% for this age group in 2006. Although multiresistance, defined as nonsusceptibility to penicillin, erythromycin, and tetracycline, was fairly rare (5.1% in 2006), 38% of the erythromycin-nonsusceptible isolates were also penicillin nonsusceptible, while 74% of the penicillin-nonsusceptible isolates were nonsusceptible to erythromycin. In contrast to the situation in continental Europe, but mirroring that in North America, the most frequent macrolide resistance determinant carried by 56% of the tested macrolide-resistant pneumococci was the\n            <jats:italic>mef<\/jats:italic>\n            gene. Serotypes 14, 9V, 19A, 6B, and 19F were most frequently nonsusceptible to erythromycin or penicillin. The penicillin-resistant invasive isolates (\n            <jats:italic>n<\/jats:italic>\n            = 88) were genotyped by multilocus sequence typing, which revealed the presence of 25 sequence types, 9 of which were novel. The majority of the isolates were related to one of several globally disseminated penicillin- or multiresistant clones, most importantly the\n            <jats:italic>rlrA<\/jats:italic>\n            adhesion pilus carrying clones Spain\n            <jats:sup>9V<\/jats:sup>\n            ST156 and Taiwan\n            <jats:sup>19F<\/jats:sup>\n            ST236. The penicillin-resistant pneumococcal population in Finland is therefore a combination of internationally recognized genotypes as well as novel ones.\n          <\/jats:p>","DOI":"10.1128\/aac.01464-08","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T01:23:34Z","timestamp":1236648214000},"page":"2066-2073","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":35,"title":["Temporal Trends of Antimicrobial Resistance and Clonality of Invasive\n            <i>Streptococcus pneumoniae<\/i>\n            Isolates in Finland, 2002 to 2006"],"prefix":"10.1128","volume":"53","author":[{"given":"Lotta","family":"Siira","sequence":"first","affiliation":[{"name":"Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merja","family":"Rantala","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Jalava","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti J.","family":"Hakanen","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pentti","family":"Huovinen","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarja","family":"Kaijalainen","sequence":"additional","affiliation":[{"name":"Department of Lifecourse and Services, National Institute for Health and Welfare, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Outi","family":"Lyytika\u0308inen","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anni","family":"Virolainen","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-8-41"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1179\/joc.2006.18.6.603","volume":"18","year":"2006","unstructured":"Altraja, A., P. Naaber, E. Tamm, S. Meriste, A. Kullamaa, and H. Leesik. 2006. Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia. J. Chemother.18:603-609.","journal-title":"J. Chemother."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.9.3313-3318.2002"},{"key":"e_1_3_2_5_2","first-page":"387","volume":"313","year":"1996","unstructured":"Arason, V. A., K. G. Kristinsson, J. A. Sigurdsson, G. Stefansdottir, S. Molstad, and S. Gudmundsson. 1996. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ313:387-391.","journal-title":"Cross sectional prevalence study. BMJ"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/mdr.2006.12.169","volume":"12","year":"2006","unstructured":"Arason, V. A., J. A. Sigurdsson, H. Erlendsdottir, S. Gudmundsson, and K. G. Kristinsson. 2006. The role of antimicrobial use in the epidemiology of resistant pneumococci: a 10-year follow up. Microb. Drug Resist.12:169-176.","journal-title":"Microb. Drug Resist."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.4.2004-2008.2005"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000129685.04847.94"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/jac\/dkh458","volume":"54","year":"2004","unstructured":"Bruinsma, N., K. G. Kristinsson, S. Bronzwaer, P. Schrijnemakers, J. Degener, E. Tiemersma, W. Hryniewicz, J. Monen, and H. Grundmann. 2004. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother.54:1045-1050.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01563-06"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1996.01521.x"},{"key":"e_1_3_2_12_2","unstructured":"Performance standards for antimicrobial susceptibility testing; 15th informational supplement. 2005"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.4999-5006.2005"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1128\/AAC.00971-07","volume":"51","year":"2007","unstructured":"Critchley, I. A., S. D. Brown, M. M. Traczewski, G. S. Tillotson, and N. Janjic. 2007. National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. faropenem surveillance study. Antimicrob. Agents Chemother.51:4382-4389.","journal-title":"faropenem surveillance study. Antimicrob. Agents Chemother."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.8.3570-3574.2004"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.2.414-417.2000"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh469"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1017\/S0950268807009405","volume":"136","year":"2008","unstructured":"Dias, R., and M. Canica. 2008. Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal. Epidemiol. Infect.136:928-939.","journal-title":"Epidemiol. Infect."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00198-06"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100960000321"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-144-11-3049"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.10.022"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000253059.84602.c3"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2007.04.006"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/107662904323047772"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000154326.77617.3e"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.9.4194-4216.2003"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1179\/joc.2007.19.5.519","volume":"19","year":"2007","unstructured":"Hajdu, E., M. Matuz, R. Benko, A. Ordas, and E. Nagy. 2007. An 8-year evaluation of antibiotic consumption and antibiotic resistance among Streptococcus pneumoniae from in- and out-patients in Szeged, Hungary. J. Chemother.19:519-527.","journal-title":"J. Chemother."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.2217\/17460913.3.1.23"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.11.6.589-592.1980"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2338"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2007.19.5.536"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-7-1"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2007.01.019"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200107000-00004"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/2006\/835768","volume":"17","year":"2006","unstructured":"McClure, C. A., M. W. Ford, J. B. Wilson, and J. J. Aramini. 2006. Pneumococcal conjugate vaccination in Canadian infants and children younger than five years of age: recommendations and expected benefits. Can. J. Infect. Dis. Med. Microbiol.17:19-26.","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.7.2565-2571.2001"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31805cdbeb"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70017-3"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1179\/joc.2006.18.4.389","volume":"18","year":"2006","unstructured":"Montagnani, F., L. Stolzuoli, A. Zanchi, S. Cresti, and C. Cellesi. 2006. Antimicrobial susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: surveillance from 1993 to 2004 in central Italy. J. Chemother.18:389-393.","journal-title":"J. Chemother."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/528375"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/524660"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1086\/498043"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.6.1832-1835.2003"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf033"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01541.x"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.14.1668"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.5.1855-1858.2006"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.10.4180-4184.2005"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0321-5"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01072-06"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki327"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.16.1784"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705589104"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2006.9994"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00524-06"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1086\/500941","volume":"42","year":"2006","unstructured":"Steenhoff, A. P., S. S. Shah, A. J. Ratner, S. M. Patil, and K. L. McGowan. 2006. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin. Infect. Dis.42:907-914.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.8.1817"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1378\/chest.130.3.800","volume":"130","year":"2006","unstructured":"Valles, X., A. Marcos, M. Pinart, R. Piner, F. Marco, J. M. Mensa, and A. Torres. 2006. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: has resistance to antibiotics decreased? Chest130:800-806.","journal-title":"Chest"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg348"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm273"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01464-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01464-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:27:30Z","timestamp":1645475250000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01464-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1128\/AAC.01464-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.01464-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"2008-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-03-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}